Text Size

"Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic"

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Scranton-Temple Residency Program.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Scranton-Temple Residency Program
ClinicalTrials.gov Identifier:
NCT00984685
First received: September 24, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
  Purpose

The purpose of the study is to identify the barriers for effective treatment of depression, specifically whether modified CHIS Scale is a valid tool for identifying the high risk patients for depression.


Condition
Depression

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: "Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic"

Resource links provided by NLM:

MedlinePlus related topics: Depression
U.S. FDA Resources

Further study details as provided by Scranton-Temple Residency Program:

Primary Outcome Measures:
  • proportion of anti-depressant prescriptions filled [ Time Frame: August 1, 2008 through July 31, 2009 ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: August 2009
Estimated Study Completion Date: October 2009
Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
depression
Patients diagnosed with depression before April 15, 2009

Detailed Description:

Depression is a major illness that affects 10% of the population in a medical setting. It is often under diagnosed and under treated. It is an illness that can challenge a persons ability to perform even routine daily activities. Review of the charts of patients diagnosed with depression showed 80% of the patients do not have follow up appointments. We wondered if modified CHIS scale could identify the risk factors for medication non-adherence.

We hypothesised that modified CHIS Scale an effective tool ,for identifying the compliance of patients with the antidepressant medication.

We are conducting a retrospective cohort study at two of our residency based clinics by interviewing approximately 100 patients with CHIS Scale and PHQ9 Questionnaire on their office visits

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with the diagnosis of depression in theprimary care clinic

Criteria

Inclusion Criteria:

  • Diagnosis of depression before April 15, 2009
  • At least one visit since April 15, 2008
  • Age 18+

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00984685

Locations
United States, Pennsylvania
Scranton Temple Residency Program Recruiting
Scranton, Pennsylvania, United States, 18510
Contact: John R Guzek, MD     570-357-7731     guzekj@strpweb.org    
Principal Investigator: John R Guzek, MD            
Sub-Investigator: Srividhya R Lakshmanan, MD            
Sponsors and Collaborators
Scranton-Temple Residency Program
Investigators
Principal Investigator: John R Guzek, MD Scranton-Temple Residency Program
  More Information

No publications provided

Responsible Party: Dr. John R Guzek MD, Scranton-Temple Residency Program
ClinicalTrials.gov Identifier: NCT00984685     History of Changes
Other Study ID Numbers: STRP0002
Study First Received: September 24, 2009
Last Updated: September 24, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 21, 2013